Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

To determine the potency of the inactivated rotavirus vaccine (IRV), we developed an enzyme immunoassay (EIA) using a biotin-conjugated RV VP7-specific monoclonal antibody. RV VP7, a pivotal structural protein in the outer capsid layer, governs RV G genotypes and prompts host immune responses, including neutralizing antibodies. This EIA showed high specificity, good linearity, high precision, and high accuracy, with a low limit of detection (LOD) and a limit of quantitation (LOQ) of 0.037 µg/ml RV antigen. The EIA was evaluated and proved suitable for establishing the long-term stability of IRV drug substance (DS) and aluminum-formulated drug product (DP) when stored at -70±10°C and 5±3 °C, respectively. Our results support the use of this EIA to examine the stability and determine the potency, antigen dose, lot-to-lot consistency, and lot release of IRV products. This RV potency assay may serve as an alternative to in vivo potency tests, making it suitable for quality control tests of cGMP IRV lots in clinical trials.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jviromet.2024.115079DOI Listing

Publication Analysis

Top Keywords

inactivated rotavirus
8
rotavirus vaccine
8
determine potency
8
eia
5
potency
5
development validation
4
validation vp7-specific
4
vp7-specific eia
4
eia determining
4
determining potency
4

Similar Publications

Mechanisms of emerging technologies for inactivating foodborne viruses.

Appl Environ Microbiol

August 2025

Laboratory of Microbial Processes in Foods, Department of Food Engineering, Technology Center, Federal University of Paraíba, João Pessoa, Paraíba, Brazil.

Contamination of food and water by viruses is a major public health issue worldwide. Several viruses are associated with foodborne outbreaks, with norovirus and hepatitis A virus being the primary causes of foodborne outbreaks, followed by hepatitis E virus and rotavirus. These viruses are responsible for the majority of outbreaks reported globally, representing a significant challenge to food safety; therefore, effective viral inactivation processes are needed.

View Article and Find Full Text PDF

Pigeon circovirus (PiCV) infection, which causes young pigeon disease syndrome (YPDS) and immunosuppression, significantly impacts both the meat and racing pigeon industries. Currently, no inactivated vaccine exists for PiCV prevention, primarily due to the challenges associated with isolating the PiCV virion, except for some gene subunit vaccines express the Cap protein of PiCV. The development of detection techniques is crucial for the diagnosis of PiCV.

View Article and Find Full Text PDF

This study aimed to evaluate the effect of gamma irradiation (0.6, 1.2, and 1.

View Article and Find Full Text PDF

Postbiotics as promising tools for controlling foodborne viruses infections.

Microb Pathog

September 2025

Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address:

Foodborne viruses were ranked as the top food safety concerns in recent years and may pose a significant risk to the public's health. Any stage of the food supply chain can experience viral contamination of food, and the fecal-oral route of transmission to humans, which involves contact between individuals as well as ingestion of contaminated food or water may result in a foodborne outbreak. There are some chemical, physical and non-thermal technologies for inactivation of foodborne viruses but these methods can occasionally be ineffectual and alter the food's organoleptic properties.

View Article and Find Full Text PDF

The incidence rate of suspected adverse events following immunization (AEFI) after single administration of pentavalent recombinant rotavirus attenuated live vaccine (RV5) in Chaoyang District, Beijing City from 2019 to 2021 was 362.3 per 100 000 doses. The incidence rate of AEFI after simultaneous administration with oral polio vaccine (OPV), inactivated polio vaccine (IPV), hepatitis B vaccine (HBV), Haemophilus influenzae type b (Hib), and pneumococcal conjugate vaccine 13-valent (PCV13) was 239.

View Article and Find Full Text PDF